Back to Search
Start Over
RX-P873, a Novel Protein Synthesis Inhibitor, Accumulates in Human THP-1 Monocytes and Is Active against Intracellular Infections by Gram-Positive (Staphylococcus aureus) and Gram-Negative (Pseudomonas aeruginosa) Bacteria
- Source :
- Antimicrobial Agents and Chemotherapy, Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2015, 59 (8), pp.4750-4758. ⟨10.1128/AAC.00428-15⟩
- Publication Year :
- 2015
- Publisher :
- HAL CCSD, 2015.
-
Abstract
- The pyrrolocytosine RX-P873, a new broad-spectrum antibiotic in preclinical development, inhibits protein synthesis at the translation step. The aims of this work were to study RX-P873's ability to accumulate in eukaryotic cells, together with its activity against extracellular and intracellular forms of infection by Staphylococcus aureus and Pseudomonas aeruginosa , using a pharmacodynamic approach allowing the determination of maximal relative efficacies ( E max values) and bacteriostatic concentrations ( C s values) on the basis of Hill equations of the concentration-response curves. RX-P873's apparent concentration in human THP-1 monocytes was about 6-fold higher than the extracellular one. In broth, MICs ranged from 0.125 to 0.5 mg/liter ( S. aureus ) and 2 to 8 mg/liter ( P. aeruginosa ), with no significant shift in these values against strains resistant to currently used antibiotics being noted. In concentration-dependent experiments, the pharmacodynamic profile of RX-P873 was not influenced by the resistance phenotype of the strains. E max values (expressed as the decrease in the number of CFU from that in the initial inoculum) against S. aureus and P. aeruginosa reached more than 4 log units and 5 log units in broth, respectively, and 0.7 log unit and 2.7 log units in infected THP-1 cells, respectively, after 24 h. C s values remained close to the MIC in all cases, making RX-P873 more potent than antibiotics to which the strains were resistant (moxifloxacin, vancomycin, and daptomycin for S. aureus ; ciprofloxacin and ceftazidime for P. aeruginosa ). Kill curves in broth showed that RX-P873 was more rapidly bactericidal against P. aeruginosa than against S. aureus . Taken together, these data suggest that RX-P873 may constitute a useful alternative for infections involving intracellular bacteria, especially Gram-negative species.
- Subjects :
- Staphylococcus aureus
medicine.drug_class
Antibiotics
Moxifloxacin
Ceftazidime
Microbial Sensitivity Tests
Pyrimidinones
Staphylococcal infections
medicine.disease_cause
Guanidines
Monocytes
Microbiology
03 medical and health sciences
Daptomycin
Ciprofloxacin
Vancomycin
Drug Resistance, Multiple, Bacterial
medicine
Humans
Pharmacology (medical)
Pseudomonas Infections
Cells, Cultured
ComputingMilieux_MISCELLANEOUS
030304 developmental biology
Pharmacology
Protein Synthesis Inhibitors
0303 health sciences
biology
030306 microbiology
Pseudomonas aeruginosa
Staphylococcal Infections
medicine.disease
biology.organism_classification
[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology
3. Good health
Anti-Bacterial Agents
Infectious Diseases
Bacteria
medicine.drug
Fluoroquinolones
Subjects
Details
- Language :
- English
- ISSN :
- 00664804 and 10986596
- Database :
- OpenAIRE
- Journal :
- Antimicrobial Agents and Chemotherapy, Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2015, 59 (8), pp.4750-4758. ⟨10.1128/AAC.00428-15⟩
- Accession number :
- edsair.doi.dedup.....afd919092c25f4c1689b8061729d4024
- Full Text :
- https://doi.org/10.1128/AAC.00428-15⟩